Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 25 - Drugs for disorders of the nervous system
Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
03/2003
03/19/2003EP1293195A1 Oral pharmaceutical dosage forms with reduced potential for drug abuse, comprising respiratory irritants or bitter substances
03/19/2003EP1292683A2 Secreted redox proteins
03/19/2003EP1292680A2 Agonist anti-trk-c monoclonal antibodies
03/19/2003EP1292679A1 A g-protein coupled receptor
03/19/2003EP1292678A2 G-protein coupled receptors
03/19/2003EP1292676A1 Mutation associated with epilepsy
03/19/2003EP1292621A1 Compositions and methods for the endocytic presentation of immunosuppressive factors
03/19/2003EP1292620A2 Nuclear hormone receptor
03/19/2003EP1292619A2 B7-related nucleic acids and polypeptides and their uses for immunomodulation
03/19/2003EP1292606A2 Positively-charged peptide nucleic acid analogs with improved properties
03/19/2003EP1292604A1 2-aminocarbonyl-9h-purine derivatives
03/19/2003EP1292596A1 1,3,8-triaza-spiro[4,5]decan-4-one derivatives as neurokinin receptor antagonists
03/19/2003EP1292592A1 Heterocyclic aminoalkyl pyridine derivatives as psychopharmaceuticals
03/19/2003EP1292581A1 Bicyclic cyclohexylamines and their use as nmda receptor antagonists
03/19/2003EP1292577A2 Aryl substituted pyrazoles, triazoles and tetrazoles as sodium channel blocker
03/19/2003EP1292576A1 Hydroxamic and carboxylic acid derivatives having mmp and tnf inhibitory activity
03/19/2003EP1292574A1 3-azabicyclo[3.1.0]hexane derivatives having opioid receptor affinity
03/19/2003EP1292573A2 Substituted thioacetamides
03/19/2003EP1292572A1 Propanolaminotetralines, preparation thereof and compositions containing same
03/19/2003EP1292571A2 (bis)sulfonamide derivatives
03/19/2003EP1292568A2 Benzamide ligands for the thyroid receptor
03/19/2003EP1292564A2 Aminoalcohol derivatives
03/19/2003EP1292326A2 Recombinant human cln2 protein and methods of its production and use
03/19/2003EP1292324A2 Critical illness neuropathy
03/19/2003EP1292311A2 Combination therapy for the treatment of depression comprising an antidepressant and an ampa receptor potentiator
03/19/2003EP1292308A1 Alpha,beta-unsaturated sulfones for treating proliferative disorders
03/19/2003EP1292307A2 Method of treating pain using nalbuphine and opioid antagonists
03/19/2003EP1292304A1 Zolpidem hemitartrate
03/19/2003EP1292302A2 Method of treating cardiovascular disease using rapamycin
03/19/2003EP1292294A1 Use of medium chain triglycerides for the treatment and prevention of alzheimer's disease and other diseases resulting from reduced neuronal metabolism
03/19/2003EP1292288A2 2-arachidonylglycerol (2-ag) - an inhibitor of tumor necrosis factor -alfa and neuroprotector of brain in closed head injury
03/19/2003EP1292284A2 Encapsulation of polynucleotides and drugs into targeted liposomes
03/19/2003EP1292282A2 Improved injectable dispersions of propofol
03/19/2003EP1292279A1 The use of glatiramer acetate (copolymer 1) in the treatment of central nervous system disorders
03/19/2003EP1292187A2 Transgenic animal model of neurodegenerative disorders
03/19/2003EP1278528A4 Nucleoside analogs with carboxamidine-modified bicyclic base
03/19/2003EP1257281A4 Nucleoside analogs with carboxamidine modified monocyclic base
03/19/2003EP1178984B1 1-trifluoromethyl-4-hydroxy-7-piperidinyl-aminomethylchroman derivatives
03/19/2003EP1177195B1 1-AMINO TRIAZOLO 4,3-a! QUINAZOLINE-5-ONES AND OR -5-THIONES INHIBITING PHOSPHODIESTERASE IV
03/19/2003EP1173179B1 Use of saredutant and the pharmaceutically acceptable salts thereof to produce medicaments used to treat or prevent major depressive disorders
03/19/2003EP1140088A4 Controlled/modified release oral methylphenidate formulations
03/19/2003EP1114049B1 3-bicycloindole compounds as 5-ht1d receptor ligands
03/19/2003EP1037637B1 Use of 5ht1a receptor antagonists for preventing and/or treating temporal lobe epilepsy
03/19/2003EP0973390A4 Retinoid related molecules for the inhibition of endothelin-1 overproduction in disease
03/19/2003EP0934312B1 1,4-disubstituted piperazines
03/19/2003EP0888309B1 Imidazole derivatives having affinity for alpha2 receptors activity
03/19/2003EP0874847B1 Novel purine derivatives having, in particular, antiproliferative properties, and biological uses thereof
03/19/2003EP0702559B1 Multiple botulinum toxins for treating neuromuscular disorders and conditions
03/19/2003EP0463101B2 Vaccination and methods against diseases resulting from pathogenic responses by specific t cell populations
03/19/2003CN1404488A NOGO receptor-mediated blockade of axonal growth
03/19/2003CN1404483A New AZa-indolyl derivatives
03/19/2003CN1404482A Pteridine compounds for the treatment of psoriasis
03/19/2003CN1404481A Nicotinamide benzofused-heterocyclyl derivatives useful as selective inhibitors of PDE4 isozymes
03/19/2003CN1404480A Pyrimidine carboxamides useful as inhibitors of PDE4 isozymes
03/19/2003CN1404479A Novel 1,3-dihydro-2H-indol-2-one derivatives their preparing method and the pharmceutical composition containing the same
03/19/2003CN1404478A Pyridinylimidazoles
03/19/2003CN1404477A 哌嗪和哌啶衍生物 Piperazine and piperidine derivatives
03/19/2003CN1404476A Glycosidase inhibitors and preparation thereof
03/19/2003CN1404472A Dihydro-1,3,5-triazine amine derivatives and their therapeutic uses
03/19/2003CN1404470A 2-OXo-1-pyrrolidine derivatives, process for preparing them and their uses
03/19/2003CN1404469A 2-Oxo-1-pyrrolidine derivatives, processes for preparing them and their uses
03/19/2003CN1404468A Novel use of phenylheteroalkylamine derivatives
03/19/2003CN1404400A Use of IL-18 inhibitors
03/19/2003CN1404393A Use of a compound for preparing a drug
03/19/2003CN1404388A Multi-step drug dosage forms
03/19/2003CN1403455A Synthesis of 2-oxazolidone derivate by one still process
03/19/2003CN1403454A N-substituted nitrogen heterocyclic compound
03/19/2003CN1403445A N-substituted nitrogen heterocyclic compound
03/19/2003CN1403133A Chinese herbal medicine prepn for stopping drug addiction
03/19/2003CN1403132A Chinese herbal medicine prepn for stopping drug addiction
03/19/2003CN1403131A Chinese herbal medicine prepn for stopping drug addiction
03/19/2003CN1403129A Chinese medicine prepn for stopping drug addiction
03/19/2003CN1403109A Recipe and prepn of medicine for stopping drug addiction
03/19/2003CN1403078A Slow-releasing prepn containing p-acetamidophenol and opium
03/19/2003CN1403076A Multi-particle improved release composition
03/19/2003CN1103220C Medicinal composition for treating optic atrophy
03/18/2003US6535943 Information processing device enabling floating interrupt to be pending and a method executing an interrupt condition change instruction
03/18/2003US6534652 Intermediates for the preparation of substituted 1,2,3,4-tetrahydronaphthalene derivatives
03/18/2003US6534544 Methods of treatment with compounds having RARα receptor specific or selective activity
03/18/2003US6534518 Polysubstituted 6-phenylphenanthridines with PDE-IV inhibiting activity
03/18/2003US6534515 20,21-dinor-eburnamenines
03/18/2003US6534507 Methods for treating psychological disorders using bioactive metabolites of gepirone
03/18/2003US6534505 Therapeutic polymorphs of a GABA-A alpha-5 inverse agonist and pamoate formulations of the same
03/18/2003US6534500 Use of cyamemazine in the treatment of abrupt benzodiazephine withdrawal
03/18/2003US6534495 Anticoagulants that prevent thrombin-related diseases.
03/18/2003US6534299 Peptide for use in development of human diagnostics and therapeutics; for use in deection and treatment of cancer, inflammation, immune disorders and development defects
03/18/2003US6534289 Recombinant nucleic acid encoding receptor having amino acid sequences of extracellular domain of G-protein coupled calcium receptor, seven-transmembrane and intracellular cytoplasmic tail domains of group I metabotropic glutamate receptor
03/18/2003US6534261 Regulation of endogenous gene expression in cells using zinc finger proteins
03/18/2003US6534048 Aqueous gel in unit dose form for topical delivery
03/18/2003US6534036 Biological materials and methods useful in the diagnosis and treatment of diseases
03/18/2003CA2269994C 7-hetero-bicyclo¬2.2.1|-heptanes
03/18/2003CA2268028C 3-alkoxyisoxazol-4-yl-substituted 2-amino carboxylic acid compounds
03/18/2003CA2162708C Bicyclic amide derivatives and their use as muscle relaxants
03/18/2003CA2141048C Substituted benzylamino nitrogen containing non-aromatic heterocycles
03/14/2003WO2002026710A1 5-phenylbenzylamine compounds, process for their production and intermediates for their synthesis
03/14/2003CA2422613A1 5-phenylbenzylamine compound, process for preparing the same and synthetic intermediate thereof
03/13/2003WO2003021262A1 Screening method
03/13/2003WO2003021225A2 Method for classification of anti-psychotic drugs
03/13/2003WO2003020932A1 Novel secretory proteins and dna thereof
03/13/2003WO2003020930A1 IDENTIFICATION AND USE OF MAMMALIAN p21 INHIBITORS
1 ... 1237 1238 1239 1240 1241 1242 1243 1244 1245 1246 1247 1248 1249 1250 1251 1252 1253 1254 1255 1256 1257 ... 1833